Ting Deng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor (NCT06484790) | Ting Deng | 2024-04-08 |
Track Ting Deng automatically
Every clearance here is in the API, with alerts when new ones post.